MYIClass II
System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies
21 CFR 866.1640 / Microbiology
MYI is the FDA product code for System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies, a class II device type, regulated under 21 CFR 866.1640. As of , FDA records hold 10 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- MYI
- Device name
- System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies
- Regulation
- 21 CFR 866.1640
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 10
- Ingested recalls
- 0
Clearances, product code MYI
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1999 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2006 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2014 | 2 |
Applicants with the most clearances
Product code MYI| Applicant | Clearances |
|---|---|
| Alere Scarborough, Inc. | 2 |
| Binax, Inc. | 2 |
| Id Biomedical Corp. | 2 |
| Advandx, Inc. | 1 |
| Denka Seiken'S | 1 |
| Mast Group Ltd. | 1 |
| Oxoid, Ltd. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
